These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18201950)

  • 61. Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.
    Kim E; Otgontenger U; Jamsranjav A; Kim SS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932623
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum amyloid A1 is involved in amyloid plaque aggregation and memory decline in amyloid beta abundant condition.
    Jang S; Jang WY; Choi M; Lee J; Kwon W; Yi J; Park SJ; Yoon D; Lee S; Kim MO; Ryoo ZY
    Transgenic Res; 2019 Dec; 28(5-6):499-508. PubMed ID: 31407125
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mulberry Fruit Extract Alleviates Cognitive Impairment by Promoting the Clearance of Amyloid-β and Inhibiting Neuroinflammation in Alzheimer's Disease Mice.
    Liu D; Du D
    Neurochem Res; 2020 Sep; 45(9):2009-2019. PubMed ID: 32488469
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
    Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
    Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease.
    Heras-Sandoval D; Pedraza-Chaverri J; Pérez-Rojas JM
    J Neuroinflammation; 2016 Mar; 13(1):61. PubMed ID: 26965310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease.
    Nasiri E; Sankowski R; Dietrich H; Oikonomidi A; Huerta PT; Popp J; Al-Abed Y; Bacher M
    Mol Med; 2020 Apr; 26(1):34. PubMed ID: 32303185
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inflammatory mechanisms in Alzheimer disease: the role of beta-amyloid/glial interactions.
    Pachter JS
    Mol Psychiatry; 1997 Mar; 2(2):91-5. PubMed ID: 9106224
    [No Abstract]   [Full Text] [Related]  

  • 70. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.
    Farfara D; Lifshitz V; Frenkel D
    J Cell Mol Med; 2008 Jun; 12(3):762-80. PubMed ID: 18363841
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
    Lee HG; Casadesus G; Zhu X; Castellani RJ; McShea A; Perry G; Petersen RB; Bajic V; Smith MA
    Neurochem Int; 2009 Feb; 54(2):84-8. PubMed ID: 19114068
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex.
    Martin LJ; Pardo CA; Cork LC; Price DL
    Am J Pathol; 1994 Dec; 145(6):1358-81. PubMed ID: 7992840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease.
    Afkhami-Goli A; Noorbakhsh F; Keller AJ; Vergnolle N; Westaway D; Jhamandas JH; Andrade-Gordon P; Hollenberg MD; Arab H; Dyck RH; Power C
    J Immunol; 2007 Oct; 179(8):5493-503. PubMed ID: 17911636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Artemether Activation of AMPK/GSK3
    Li S; Zhao X; Lazarovici P; Zheng W
    Oxid Med Cell Longev; 2019; 2019():1862437. PubMed ID: 31871541
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications.
    Di Bona D; Scapagnini G; Candore G; Castiglia L; Colonna-Romano G; Duro G; Nuzzo D; Iemolo F; Lio D; Pellicanò M; Scafidi V; Caruso C; Vasto S
    Curr Pharm Des; 2010; 16(6):684-91. PubMed ID: 20388078
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tipping points in neurodegeneration.
    Simons M; Levin J; Dichgans M
    Neuron; 2023 Oct; 111(19):2954-2968. PubMed ID: 37385247
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.
    Griffin WS; Sheng JG; Royston MC; Gentleman SM; McKenzie JE; Graham DI; Roberts GW; Mrak RE
    Brain Pathol; 1998 Jan; 8(1):65-72. PubMed ID: 9458167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phagocytic clearance in neurodegeneration.
    Sokolowski JD; Mandell JW
    Am J Pathol; 2011 Apr; 178(4):1416-28. PubMed ID: 21435432
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Periodontitis and Alzheimer´s disease.
    Sansores-España D; Carrillo-Avila A; Melgar-Rodriguez S; Díaz-Zuñiga J; Martínez-Aguilar V
    Med Oral Patol Oral Cir Bucal; 2021 Jan; 26(1):e43-e48. PubMed ID: 32701930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.